ASIA PACIFIC BREAST IMPLANTS MARKET ANALYSIS

Asia Pacific Breast Implants MarketSize and Trends

Asia Pacific Breast Implants Market is estimated to be valued at US$   371.5 million in 2023 and is expected to exhibit a CAGR of 8.74% during the forecast period (2023-2030). Increasing prevalence of the breast cancer in the Asia Pacific region is expected to drive the market growth over the forecast period for the Asia Pacific region. For instance, in September 2022, according to the data published by the National Center for Biotechnology Information, it was stated that India has the highest breast cancer mortality rates, which was found to be 12.7 per 100,000 cases. Furthermore, according to the Centers for Disease Control and Prevention, it was found that the cancer incidence in Asia Pacific was 169.1 per 1,00,000 in the year 2021, accounting for 49.3% of the global cancer incidence.

Asia Pacific Breast Implants Market - Driver

Increasing clinical trial study to evaluate safety and efficacy of the breast implants to drive the Asia Pacific breast implants market over the forecast period

Th major market player are focused on carrying out clinical trials for launching new breast implants in the market. For instance, in June 2022, BellaSeno Pty Ltd, medical technology company, an Australia-based company, initiated a clinical trial for surgical implantation of the PCL breast scaffold with autologous fat grafting. The clinical trial study is estimated to get completed by June, 2026.

Increasing launch of the next generation of breast implants by the key players operating in the market

Key market players are adopting growth strategies such as launching next generation of breast implants in the market, which is expected to drive the Asia Pacific breast implants market over the forecast period. For instance, in May 2021, GC Aesthetics, Inc., medical technology company, announced the launched of the Perle, a next generation of breast implant. Perle is an innovative line of smooth breast implants that characterize a proprietary surface technology (BioQ) GC Aesthetics, Inc. company’s industry-leading gel technology (Emunomic Breast Tissue Dynamic Gel), and an enhanced version of the safety features.

Figure 2. Asia Pacific Breast Implants Market  Share (%), by Country, 2023